Oleoyl-L-carnitine inhibits glycine transport by GlyT2

British Journal of Pharmacology

Volumn 168, Issue 4, 2013, Pages 891-902

  Carland, J E ^a   Mansfield, R E ^a   Ryan, R M ^a   Vandenberg, R J ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

acylcarnitine; glycine transporter; lipid modulator; oleoyl l carnitine

Indexed keywords

ACYLCARNITINE DERIVATIVE; ANALGESIC AGENT; CARNITINE DERIVATIVE; CARNITINE OLEATE; GLYCINE; GLYCINE DERIVATIVE; GLYCINE TRANSPORTER 1; GLYCINE TRANSPORTER 2; ISOLEUCINE; LAUROYLCARNITINE; LINOLEOYLCARNITINE; N ARACHIDONYLGLYCINE; PALMITOYLCARNITINE; STEAROYLCARNITINE; UNCLASSIFIED DRUG;

AMINO ACID TRANSPORT; ANIMAL CELL; ARTICLE; CHIMERA; CONTROLLED STUDY; DRUG MECHANISM; DRUG STRUCTURE; ELECTROPHYSIOLOGY; IC 50; NONHUMAN; OOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; XENOPUS LAEVIS;

ANIMALS; BIOLOGICAL TRANSPORT; CARNITINE; DOSE-RESPONSE RELATIONSHIP, DRUG; GLYCINE; GLYCINE PLASMA MEMBRANE TRANSPORT PROTEINS; MOLECULAR STRUCTURE; OOCYTES; PATCH-CLAMP TECHNIQUES; XENOPUS LAEVIS;

EID: 84872920579     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.2012.02213.x     Document Type: Article

References (42)

1. Alexander SPH, Mathie, A, Peters JA, (2011). Guide to Receptors and Channels (GRAC), 5th edn. Br. J. Pharmacol 164 (Suppl. 1): S1-S324.
2. Andersen J, Taboureau O, Hansen KB, Olsen L, Egebjerg J, Strømgaard K, et al. (2009). Location of the antidepressant binding site in the serotonin transporter: importance of Ser-438 in recognition of citalopram and triccyclic antidepressants. J Biol Chem 284: 10276-10284.
3. Atkinson BN, Bell SC, De Vivo M, Kowalski LR, Lechner SM, Ognyanov VI, et al. (2001). ALX 5407: a potent, selective inhibitor of the hGlyT1 glycine transporter. Mol Pharmacol 60: 1414-1420.
4. Aubrey KR, Vandenberg RJ, (2001). N[3-(4-fluorophenyl)-3-(4- phenylphenoxy)propyl]sarcosine (NFPS) is a selective persistent inhibitor of glycine transport. Br J Pharmacol 134: 1429-1436.
5. Bradbury MW, Stump D, Guarnieri F, Berk PD, (2011). Molecular modeling and functional confirmation of a predicted fatty acid binding site of mitochondrial aspartate aminotransferase. J Mol Biol 412: 412-422.
6. Chattopadhyay A, London E, (1984). Fluorimetric determination of critical micelle concentration avoiding interference from detergent charge. Anal Biochem 139: 408-412.
7. Chiechio S, Caricasole A, Barletta E, Storto M, Catania MV, Copani A, et al. (2002). L-Acetylcarnitine induces analgesia by selectively up-regulating mGlu2 metabotropic glutamate receptors. Mol Pharmacol 61: 989-996.
8. Cho KS, Proulx P, (1971). Studies on the mechanism of hemolysis by acyl carnitines, lysolecithins and acyl cholines. Biochim Biophys Acta 225: 214-223.
9. Connor M, Vaughan CW, Vandenberg RJ, (2010). N-Acyl amino acids and N-Acyl neurotransmitter conjugates: neuromodulators and probes for new drug targets. Br J Pharmacol 160: 1857-1871.
10. Doi N, Tomita M, Hayashi M, (2011). Absorption enhancement effect of acylcarnitines through changes in tight junction protein in Caco-2 cell monolayers. Drug Metab Pharmacokinet 26: 162-170.
11. Edington AR, McKinzie AA, Reynolds AJ, Kassiou M, Ryan RM, Vandenberg RJ, (2009). Extracellular loops 2 and 4 of GLYT2 are required for N-Arachidonylglycine inhibition of glycine transport. J Biol Chem 284: 36424-36430.
12. Eulenburg V, Armsen W, Betz H, Gomeza J, (2005). Glycine transporters: essential regulators of neurotransmission. Trends Biochem Sci 30: 325-333.
13. Fix JA, Engle K, Porter PA, Leppert PS, Selk SJ, Gardner CR, et al. (1986). Acylcarnitines: drug absorption-enhancing agents in the gastrointestinal tract. Am J Physiol 251: G332-G340.
14. Foster DW, (2004). The role of the carnitine system in human metabolism. Ann N Y Acad Sci 1033: 1-16.
15. Gasbarri C, Guernelli S, Boncompagni S, Angelini G, Siani G, De Maria P, et al. (2010). Fine-tuning of POPC liposomal leakage by the use of beta-cyclodextrin and several hydrophobic guests. J Liposome Res 20: 202-210.
16. Jeong HJ, Vandenberg RJ, Vaughan CW, (2009). N-Arachidonyl-glycine modulates synaptic transmission in superficial dorsal horn. Br J Pharmacol 161: 925-935.
17. Jones LL, McDonald DA, Borum PR, (2010). Acylcarnitines: role in brain. Prog Lipid Res 49: 61-75.
18. Ju P, Aubrey KR, Vandenberg RJ, (2004). Zn2+ inhibits glycine transport by glycine transporter subtype 1b. J Biol Chem 279: 22983-22991.
19. Kim KM, Kingsmore SF, Han H, Yang-Feng TL, Godinot N, Seldin MF, et al. (1994). Cloning of the human glycine transporter type 1: molecular and pharmacological characterization of novel isoform variants and chromosomal localization of the gene in the human and mouse genomes. Mol Pharmacol 45: 608-617.
20. Kinney GG, Sur C, Burno M, Mallorga PJ, Williams JB, Figueroa DJ, et al. (2003). The glycine transporter type 1 inhibitor N-[3-(4-fluorophenyl)-3-(4- phenylphenoxy)propyl]sarcosine potentiates NMDA receptor-mediated responses in vivo and produces an antipsychotic profile in rodent behavior. J Neurosci 23: 7586-7591.
21. Krishnamurthy H, Gouaux E, (2012). X-ray structures of LeuT in substrate-free outward-open and apo inward-open states. Nature 481: 469-474.
22. Lechner S, (2006). Glutamate-based theraputic approaches:inhibitors of glycine transport. Curr Opin Pharmacol 6: 75-81.
23. LeCluyse EL, Appel LE, Sutton SC, (1991). Relationship between drug absorption enhancing activity and membrane perturbing effects of acylcarnitines. Pharm Res 8: 84-87.
24. Liu QR, Lopez-Corcuera B, Mandiyan S, Nelson H, Nelson N, (1993). Cloning and expression of a spinal cord- and brain-specific glycine transporter with novel structural features. J Biol Chem 268: 22802-22808.
25. Liu X, Mitrovic AD, Vandenberg RJ, (2009). Glycine transporter 1 associates with cholesterol-rich membrane raft microdomains. Biochem Biophys Res Commun 384: 530-534.
26. Lynch JW, (2004). Molecular structure and function of the glycine receptor chloride channel. Physiol Rev 84: 1051-1095.
27. Pantano D, Klein M, (2009). Characterization of membrane-protein interactions for the leucine transporter from aquifex aeolicus by molecular dynamics calculations. J Phys Chem B 113: 13715-13722.
28. Pearlman RJ, Aubrey KR, Vandenberg RJ, (2003). Arachidonic acid and anandamide have opposite modulatory actions at the glycine transporter, GLYT1a. J Neurochem 84: 592-601.
29. Singh SK, Yamashita A, Gouaux E, (2007). Antidepressant binding site in a bacterial homologue of neurotransmitter transporters. Nature 448: 952-956.
30. Singh SK, Piscitelli CL, Yamashita A, Gouaux E, (2008). A competitive inhibitor traps LeuT in an open-to-out conformation. Science 322: 1655-1661.
31. Succar R, Mitchell VA, Vaughan CW, (2007). Actions of N-Arachidonyl-glycine in a rat inflammatory pain model. Mol Pain 3: 24.
32. Supplisson S, Bergman C, (1997). Control of NMDA receptor activation by a glycine transporter co-expressed in Xenopus oocytes. J Neurosci 17: 4580-4590.
33. Sur C, Kinney GG, (2004). The therapeutic potential of glycine transporter-1 inhibitors. Expert Opin Investig Drugs 13: 515-521.
34. Tonazzi A, Console L, Giangregorio N, Indiveri C, Palmieri F, (2012). Identification by site-directed mutagenesis of a hydrophobic binding site of the mitochondrial carnitine/acylcarnitine carrier involved in the interaction with acyl groups. Biochim Biophys Acta 1817: 697-704.
35. Traynelis SF, Wollmuth LP, McBain CJ, Menniti FS, Vance KM, Ogden KK, et al. (2010). Glutamate receptor ion channels: structure, regulation, and function. Pharmacol Rev 62: 405-496.
36. Vandenberg RJ, Aubrey KR, (2001). Glycine transport inhibitors as potential antipsychotic drugs. Expert Opin Ther Targets 5: 507-518.
37. Vandenberg RJ, Mitrovic AD, Johnston GA, (1998). Serine-O-sulphate transport by the human glutamate transporter, EAAT2. Br J Pharmacol 123: 1593-1600.
38. Vandenberg RJ, Shaddick K, Ju P, (2008). Molecular basis for substrate discrimination by glycine transporters. J Biol Chem 282: 14447-14453.
39. Vuong LA, Mitchell VA, Vaughan CW, (2008). Actions of N-Arachidonyl-glycine in a rat neuropathic pain model. Neuropharmacology 54: 189-193.
40. Wiles AL, Pearlman RJ, Rosvall M, Aubrey KR, Vandenberg RJ, (2006). N-Arachidonyl-glycine inhibits the glycine transporter, GLYT2a. J Neurochem 99: 781-786.
41. Xu TX, Gong N, Xu TL, (2005). Inhibitors of GlyT1 and GlyT2 differentially modulate inhibitory transmission. Neuroreport 16: 1227-1231.
42. Yamashita A, Singh SK, Kawate T, Jin Y, Gouaux E, (2005). Crystal structure of a bacterial homologue of Na+/Cl-dependent neurotransmitter transporters. Nature 437: 215-223.